VectorBuilder and MaxCyte formed a strategic partnership focused on co-developing a new gene delivery solution using VectorBuilder’s MiniVec™ plasmid system and MaxCyte’s clinical electroporation ...

With an increasingly promising roster of approved cell therapies still burdened by complex manufacturing, multiple companies have emerged in recent years on a mission to simplify production for the ...

The federal law putting into place education, registration and — for non-depository originators — licensing requirements, applies only to human beings. Yet, don't count on an all-automated loan ...

A Los Angeles-based Justice Department official late Friday debunked a baseless claim of a discrepancy in the vote count of the city’s mayoral race that has circulated on social media. The claim, ...

Alternative splicing plays crucial roles in normal heart development and cardiac disease by influencing protein-coding sequences, functional domains, and molecular networks. However, a detailed ...

Running extreme distances may strain more than just muscles and joints. New research suggests ultramarathons can alter red blood cells in ways that make them less flexible and more prone to breakdown, ...

Alternative therapies that aid the body's immune system to fight bacteria have shown promise in addressing the global threat of antibiotic resistance. University of Queensland researchers have found ...

Building on Version 1 of the U.S. military’s so-called Bumblebee counter- drone system, the Joint Inter-Agency Task Force (JIATF) 401 began testing initial prototypes of the second iteration on April ...

MSU cuts ribbon on automated composite stitching cell On Monday [April 13], Mississippi State President Mark E. Keenum, fourth from left, participated in a ribbon-cutting ceremony for the university’s ...

Celloraa said it expects to begin producing cells at the site at the end of the 2026-27 financial year. Image: RENA Technologies German wet processing equipment manufacturer RENA Technologies will ...